VisionPoint Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$987K Sell
12,614
-25,744
-67% -$2.08M 0.16% 146
2026
Q1
$3.32M Buy
38,358
+14,760
+63% +$1.41M 0.63% 37
2025
Q4
$2.27M Buy
23,598
+3,640
+18% +$354K 0.44% 62
2025
Q3
$1.9M Buy
19,958
+8,441
+73% +$776K 0.38% 72
2025
Q2
$1M Buy
11,517
+1,225
+12% +$104K 0.22% 113
2025
Q1
$925K Buy
10,292
+9,266
+903% +$829K 0.32% 73
2024
Q4
$82.3K Buy
+1,026
New +$88.8K 0.03% 244
2024
Q3
Sell
-1,032
Closed -$81.2K 559
2024
Q2
$81.2K Sell
1,032
-54
-5% -$4.43K 0.03% 227
2024
Q1
$94.6K Buy
1,086
+4
+0.4% +$341 0.03% 211
2023
Q4
$89.1K Sell
1,082
-1,291
-54% -$98.4K 0.03% 197
2023
Q3
$186K Sell
2,373
-50
-2% -$4.19K 0.08% 146
2023
Q2
$213K Sell
2,423
-100
-4% -$8.61K 0.09% 126
2023
Q1
$225K Sell
2,523
-30
-1% -$2.44K 0.1% 135
2022
Q4
$215K Hold
2,553
0.09% 129
2022
Q3
$206K Sell
2,553
-225
-8% -$20.2K 0.1% 87
2022
Q2
$261K Buy
+2,778
New +$281K 0.1% 86
2022
Q1
Sell
-2,705
Closed -$278K 99
2021
Q4
$278K Buy
2,705
+50
+2% +$5.79K 0.12% 85
2021
Q3
$326K Buy
2,655
+33
+1% +$4.27K 0.15% 82
2021
Q2
$325K Buy
+2,622
New +$329K 0.14% 80
2020
Q4
Sell
-3,883
Closed -$404K 151
2020
Q3
$404K Hold
3,883
0.17% 70
2020
Q2
$374K Buy
+3,883
New +$372K 0.15% 63

Other funds holding MDT

VisionPoint Advisory Group's MDT Position: Q2 2026 in Review

VisionPoint Advisory Group reduced its Medtronic (MDT) stake by 67% in Q2 2026, selling an estimated $2.08M and leaving 12,614 shares worth $987K. The position accounts for 0.16% of the portfolio, ranked #146.

VisionPoint Advisory Group first reported a position in MDT in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.32M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • VisionPoint Advisory Group held 12,614 shares of Medtronic worth $987K as of Q2 2026.
  • VisionPoint Advisory Group sold 25,744 Medtronic shares in Q2 2026, an estimated $2.08M.
  • Medtronic made up 0.16% of VisionPoint Advisory Group's portfolio in Q2 2026, its #146 holding.
  • VisionPoint Advisory Group first reported a position in Medtronic in Q2 2020 and has held it in 21 quarters since.
  • VisionPoint Advisory Group's Medtronic position peaked at $3.32M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.